NCT03080740

The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis

The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet for the Treatment of Bacterial Vaginosis

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: Guangzhou Yipinhong Pharmaceutical CO.,LTD · Industry
• Sex: Female
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

Randomized, double blind, positive drug parallel comparison, multi-centre clinical trial to assess the Efficacy and Safety of Clindamycin palmitate hydrochloride dispersible tablet for the treatment of bacterial vaginosis

Detailed description

Treatment group: Clindamycin palmitate hydrochloride dispersible tablet . Control group: Metronidazole Tablet.

Conditions

• Bacterial Vaginosis

Interventions

Type	Name	Description
DRUG	Clindamycin palmitate hydrochloride dispersible tablet	300mg, oral after meal, twice daily, a total of 7days
DRUG	Metronidazole Tablet	400mg, oral after meal , twice daily, a total of 7days

Timeline

• Start date: 2016-07-01
• Primary completion: 2017-07-01
• Completion: 2017-12-01
• First posted: 2017-03-15
• Last updated: 2017-03-15

Locations

1 site across 1 country: China